367 related articles for article (PubMed ID: 19638465)
1. Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Lee DH; Ahn Y; Kim SU; Wang KC; Cho BK; Phi JH; Park IH; Black PM; Carroll RS; Lee J; Kim SK
Clin Cancer Res; 2009 Aug; 15(15):4925-34. PubMed ID: 19638465
[TBL] [Abstract][Full Text] [Related]
2. Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
Kim SK; Kim SU; Park IH; Bang JH; Aboody KS; Wang KC; Cho BK; Kim M; Menon LG; Black PM; Carroll RS
Clin Cancer Res; 2006 Sep; 12(18):5550-6. PubMed ID: 17000692
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
[TBL] [Abstract][Full Text] [Related]
4. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
5. Stereological analysis on migration of human neural stem cells in the brain of rats bearing glioma.
Kim JH; Lee JE; Kim SU; Cho KG
Neurosurgery; 2010 Feb; 66(2):333-42; discussion 342. PubMed ID: 20087133
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma.
Kim JH; Kim JY; Kim SU; Cho KG
Biochem Biophys Res Commun; 2012 Jan; 417(1):534-40. PubMed ID: 22177952
[TBL] [Abstract][Full Text] [Related]
7. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
Choi SA; Lee JY; Wang KC; Phi JH; Song SH; Song J; Kim SK
Eur J Cancer; 2012 Jan; 48(1):129-37. PubMed ID: 21664124
[TBL] [Abstract][Full Text] [Related]
8. Human neural stem cells transduced with IFN-beta and cytosine deaminase genes intensify bystander effect in experimental glioma.
Ito S; Natsume A; Shimato S; Ohno M; Kato T; Chansakul P; Wakabayashi T; Kim SU
Cancer Gene Ther; 2010 May; 17(5):299-306. PubMed ID: 19893595
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered stem cells expressing cytosine deaminase and interferon-β migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects.
Yi BR; O SN; Kang NH; Hwang KA; Kim SU; Jeung EB; Kim YB; Heo GJ; Choi KC
Int J Oncol; 2011 Oct; 39(4):833-9. PubMed ID: 21769425
[TBL] [Abstract][Full Text] [Related]
11. Antitumor therapeutic effects of cytosine deaminase and interferon-β against endometrial cancer cells using genetically engineered stem cells in vitro.
Yi BR; Kang NH; Hwang KA; Kim SU; Jeung EB; Choi KC
Anticancer Res; 2011 Sep; 31(9):2853-61. PubMed ID: 21868529
[TBL] [Abstract][Full Text] [Related]
12. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
[TBL] [Abstract][Full Text] [Related]
13. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model.
Kim SK; Cargioli TG; Machluf M; Yang W; Sun Y; Al-Hashem R; Kim SU; Black PM; Carroll RS
Clin Cancer Res; 2005 Aug; 11(16):5965-70. PubMed ID: 16115940
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
15. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
[TBL] [Abstract][Full Text] [Related]
17. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 1 enhances the ability of human umbilical cord blood-derived mesenchymal stem cells to migrate toward gliomas.
Kim SM; Kim DS; Jeong CH; Kim DH; Kim JH; Jeon HB; Kwon SJ; Jeun SS; Yang YS; Oh W; Chang JW
Biochem Biophys Res Commun; 2011 Apr; 407(4):741-6. PubMed ID: 21439934
[TBL] [Abstract][Full Text] [Related]
19. Combined treatment of tumor-tropic human neural stem cells containing the CD suicide gene effectively targets brain tumors provoking a mild immune response.
Lee SJ; Kim Y; Jo MY; Kim HS; Jin Y; Kim SU; Jin J; Joo KM; Nam DH
Oncol Rep; 2011 Jan; 25(1):63-8. PubMed ID: 21109958
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model.
Nakamura K; Ito Y; Kawano Y; Kurozumi K; Kobune M; Tsuda H; Bizen A; Honmou O; Niitsu Y; Hamada H
Gene Ther; 2004 Jul; 11(14):1155-64. PubMed ID: 15141157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
